News Search Results
Aug 28, 2024, 17:15 ET TC BioPharm Announces Closing of Upsized $6.0 Million Public Offering
Aug. 28, 2024 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer and other indications, today announced the closing of its previously
More news about: TC BioPharm
Aug 28, 2024, 13:50 ET TC BioPharm Announces Grant of European Patent Covering Use of Modified Gamma Delta Cells for the Treatment of Cancer and Viral Indications
Aug. 28, 2024 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer and other indications, today announced that it has received a patent
More news about: TC BioPharm
Aug 28, 2024, 09:00 ET Molecular Assemblies Achieves Key Milestones in DARPA NOW Project for On-Demand DNA Vaccine Manufacturing
decreases the need for lengthy and expensive post-synthesis purification. Synthetic synthesis of DNA chains is the foundation for experiments in the biotechnology and health science sectors and for seeing biology achieve its long sought after full promise. The proprietary platform is powering the exciting
More news about: Molecular Assemblies
Aug 28, 2024, 08:34 ET ADVANCION EXPANDS PERSONAL CARE PRODUCT PORTFOLIO WITH LAUNCH OF IN-HOUSE PRODUCED HEPES ULTRA PC™ BUFFER
ABOUT ADVANCIONAdvancion, formerly ANGUS Chemical Company, is a leading global producer of specialty ingredients and consumables for biotechnology, pharmaceuticals, home and personal care, and other consumer-oriented and industrial markets. The Company is one of the world's largest producers
More news about: Advancion Corporation
Aug 28, 2024, 08:30 ET Halozyme to Present at Upcoming Investor Conferences
commercialized products across more than 100 global markets, Halozyme has licensed its ENHANZE® technology to leading pharmaceutical and biotechnology companies including Roche, Takeda, Pfizer, Janssen, AbbVie, Eli Lilly, Bristol-Myers Squibb, argenx, ViiV Healthcare, Chugai Pharmaceutical and
More news about: Halozyme Therapeutics, Inc.
Aug 28, 2024, 07:31 ET VAXA Technologies Iceland: Groundbreaking Study Reveals Enhanced Natural Vitamin B12 Production in Spirulina Through Photonic Management
Berzin, CTO of VAXA, the company that invented the technology behind the breakthrough, remarked, "These findings are a significant step forward in biotechnology and sustainable nutrition. Located in Iceland next to a geothermal power plant VAXA leverage plant's resources
More news about: VAXA Technologies Iceland
Aug 28, 2024, 07:30 ET Virax Biolabs Announces Distribution Agreement to Commercialize Mpox (formerly Monkeypox) Virus RT-PCR Detection Kits in Europe and the Middle East
Aug. 28, 2024 /PRNewswire/ -- Virax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company"), an innovative biotechnology company focused on the detection of immune responses and diagnosis of viral diseases, today announced that it has entered into a distribution agreement
More news about: Virax Biolabs
Aug 28, 2024, 07:30 ET FDA Confirms Acceptability of Palatin's Remaining Phase 3 Pivotal Clinical Trials for PL9643 in Dry Eye Disease (DED)
complete clinical trials and submit applications for regulatory approvals, products developed by competing pharmaceutical, biopharmaceutical and biotechnology companies, commercial acceptance of Palatin's products, and other factors discussed in Palatin's periodic filings with the Securities and Exchange
More news about: Palatin Technologies, Inc.
Aug 28, 2024, 07:00 ET AKTIS ONCOLOGY TO PARTICIPATE IN THE MORGAN STANLEY 22ND ANNUAL GLOBAL HEALTHCARE CONFERENCE
BOSTON, Aug. 28, 2024 /PRNewswire/ -- Aktis Oncology, a clinical stage biotechnology company discovering and developing novel targeted alpha radiopharmaceuticals to treat a broad range of solid tumors, today announced that
More news about: Aktis Oncology
Aug 28, 2024, 06:37 ET Innovent Announces 2024 Interim Results and Business Updates
Products", "Empowering Employees", and "Embracing Ecology".Innovent is graded 'A' level in MSCI ESG rating, ranking at the forefront of the biotechnology industry.About Innovent Innovent is a leading biopharmaceutical company founded in 2011 with the mission to empower patients
More news about: Innovent Biologics
Aug 28, 2024, 06:30 ET Immunic to Host Multiple Sclerosis R&D Day and Participate in Scientific and Investor Conferences in September
Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today
More news about: Immunic, Inc.
Aug 28, 2024, 06:30 ET Flagship Pioneering and Quotient Therapeutics Announce Agreement to Identify Potential Novel Targets for the Treatment of Cardiovascular and Renal Diseases under Strategic Partnership with Pfizer
Sana Biotechnology (NASDAQ: SANA),
More news about: Flagship Pioneering
Aug 28, 2024, 05:44 ET Harbour BioMed Announces 2024 Interim Results
exercise these options. In July 2024, Nona Biosciences entered into a collaboration agreement with Alaya.bio, a biotechnology company developing a novel polymeric delivery platform, to precisely target and reprogram cells in situ and thus to significantly simplify
More news about: Harbour BioMed
Aug 28, 2024, 05:29 ET Hyundai Bioscience to conduct phase 3 clinical trial for high-risk group of COVID-19 patients with the goal of emergency use authorization
group patients to ensure they have access to a safe and effective treatment." About Hyundai Bioscience Hyundai Bioscience is a biotechnology company that develops new drugs based on its novel drug delivery system technologies to deliver active ingredients safely and efficiently to targeted
More news about: Hyundai Bioscience
Aug 28, 2024, 04:32 ET VAXA Technologies Iceland: Groundbreaking Study Reveals Enhanced Natural Vitamin B12 Production in Spirulina Through Photonic Management
Berzin, CTO of VAXA, the company that invented the technology behind the breakthrough, remarked, "These findings are a significant step forward in biotechnology and sustainable nutrition. Located in Iceland next to a geothermal power plant VAXA leverage plant's resources
More news about: VAXA Technologies Iceland
Aug 28, 2024, 02:50 ET BPC Instruments reports results for H1 and Q2 2024
instruments enabling more efficient, reliable, and higher quality research and analysis for industries in renewable bioenergy and environmental biotechnology. The result is not only higher accuracy and precision, but also a significant reduction in time consumption and labor requirement for performing
More news about: BPC Instruments AB
Aug 27, 2024, 18:01 ET Tampa General Hospital and USF Health Enter New Era of Academic Medicine with Increased Investments, Greater Integration, More Exceptional Care
developing Tampa's growing reputation as a global destination for exceptional care, advanced research and emerging biotechnology. The academic, research, science and technology organizations reside within the Tampa Medical and Research District, which is anchored by TGH and
More news about: Tampa General Hospital
Aug 27, 2024, 17:50 ET Wound Closure Strips Market to Grow by USD 100.7 Million from 2024-2028, Driven by Rising Efforts to Reduce Surgical Site Infections (SSIs), Including AI's Influence on Market Trends - Technavio Report
and traditional surface stitches, as well as alternatives to staples and sutures. The market is expected to grow further due to advancements in biotechnology industries and the need for effective wound closure solutions in trauma centers. Explore a 360° Analysis of the Market: Unveil
More news about: Technavio
Aug 27, 2024, 17:31 ET Global Lumbar Disc Replacement Devices Market to Exhibit Significant Growth at a CAGR of ~9% by 2030 | DelveInsight
Moebius Medical, UnicoCell Biomed CO. LTD, Gwo Xi Stem Cell Applied Technology, Bioventus LLC, CAR-T (Shanghai) Biotechnology, Novartis, Personalized Stem Cells, Centrexion Therapeutics, Akan Biosciences, Purdue Pharma, Anika Therapeutics, Peptinov SAS, Flexion Therapeutics,
More news about: DelveInsight Business Research, LLP
Aug 27, 2024, 17:10 ET Computational Fluid Dynamics Market to Grow by USD 1.23 Billion from 2024-2028, Driven by Demand for Reduced Product Design Time and Costs, Report Highlights AI's Influence on Market Trends - Technavio
improving efficiency. CFD software, hardware, and high-performance computing are essential tools for industries like renewable energy, healthcare, and biotechnology. Simulation capabilities are expanding to include industry applications like wind farms and circuit boards, with efficient product design and optimization
More news about: Technavio
Aug 27, 2024, 13:33 ET Flavorcon Returns to Atlantic City This October
Chain Disruptions in Citrus & Vanillin SectorsBeer CategoryMarket Trends in TasteThe 'Swicy' PhenomenonBiotechnology & FermentationTaste & Smell Dysfunction ResearchThe Flavorcon Expo Hall is where innovation comes to life. Immerse
More news about: Allured Business Media
Aug 27, 2024, 12:00 ET UCLA receives $120 million from Alya and Gary Michelson for new California Institute for Immunology and Immunotherapy
pharmaceuticals and treatments for patients. The institute will recruit leading scientists from around the world, create an integrated ecosystem of biotechnology startups and train the next generation of leading-edge medical researchers. As a hub of biomedical collaboration, the institute and the biomedical
More news about: UCLA Health
Aug 27, 2024, 11:54 ET Unique International Collaboration Brings Breakthrough Oral Cholera Vaccine to Market
HILLCHOL® is a result of an innovative model of international partnership between Hilleman Laboratories and Bharat Biotech, an Indian multinational biotechnology company. Today's announcement follows the successful completion of HILLCHOL® Phase III clinical trials and approval for licensure by Bharat
More news about: Hilleman Laboratories
Aug 27, 2024, 11:50 ET Unique International Collaboration Brings Breakthrough Oral Cholera Vaccine to Market
HILLCHOL® is a result of an innovative model of international partnership between Hilleman Laboratories and Bharat Biotech, an Indian multinational biotechnology company. Today's announcement follows the successful completion of HILLCHOL® Phase III clinical trials and approval for licensure by Bharat
More news about: Hilleman Laboratories
Aug 27, 2024, 10:31 ET Angel Yeast s'étend à la R&D et à la production de probiotiques, faisant ainsi progresser la transformation biotechnologique
également un vivier de talents locaux dans les domaines de la gestion, de la finance et des équipements. » La société Xizang Angel Zhufeng Biotechnology Co., Ltd. possède des droits de propriété entièrement indépendants, allant des souches clés jusqu'aux processus de production, et l'atelier de l'usine
More news about: Angel Yeast